Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Neuralstem Pipeline Rolling Forward, Tackling Major Unmet Needs
Yahoo/Zacks
Saturday, August 9, 2014 - 9:25am
tags:
Neuralstem
California judge sets Aug. 20 hearing in Allergan vs Valeant case
Yahoo/Reuters
Friday, August 8, 2014 - 5:55pm
tags:
California, Allergan, Valeant Pharmaceuticals, M&A
Neurocrine To Move Tardive Dyskinesia Drug Into Phase 3
Yahoo/Zacks.com
Friday, August 8, 2014 - 5:55pm
tags:
tardive dyskinesia, Neurocrine Biosciences, NBI-98854, earnings
GW Pharma, Insys Face Off In Cannabis Drug Space
Investors.com
Friday, August 8, 2014 - 5:53pm
tags:
GW Pharma, Insys, cannabis, Medical Marijuana
FDA regulators approve 2 new Medtronic CRT-Ds as well as a model of the Attain Performa quadripolar lead.
Mass Device
Friday, August 8, 2014 - 5:48pm
tags:
FDA, devices, Medtronic, CRT-D, Attain Performa quadripolar lead
Genentech Submits sBLA for Diabetic Retinopathy Drug
Drug Discovery and Development
Friday, August 8, 2014 - 5:08pm
tags:
Genentech, Roche, diabetic retinopathy, Lucentis
Neuralstem Pipeline Rolling Forward, Tackling Major Unmet Needs
Yahoo/Zacks.com
Friday, August 8, 2014 - 4:01pm
tags:
Neuralstem, NSI-566
GSK-linked investigator found guilty in China trial
CNBC
Friday, August 8, 2014 - 3:52pm
tags:
GSK, China, bribery
Medivation Cancer Drug Fuels Beat, Swings To Profit
Investors.com
Friday, August 8, 2014 - 12:05pm
tags:
Medivation, earnings
VBL's IPO falls apart as investor drops the ball
Fierce Biotech
Friday, August 8, 2014 - 11:58am
tags:
IPOs, Vascular Biogenics
Tolero bags $14M to take its cancer drug to Phase III
Fierce Biotech
Friday, August 8, 2014 - 11:52am
tags:
Tolero Pharmaceuticals, alvocidib, acute myeloid leukemia
Novartis can't convince judge to free it from kickbacks case
Fierce Pharma
Friday, August 8, 2014 - 11:45am
tags:
Novartis, kickbacks
Still Down? Tech Glitch Hobbles Pharma Payment Disclosure System
WSJ Online
Friday, August 8, 2014 - 11:42am
tags:
Physician Payment Sunshine Act, physicians
Salix Sinks In #PreMarket On Disappointing Outlook, Q2 Results
Yahoo/Benzinga
Friday, August 8, 2014 - 11:41am
tags:
Salix, earnings
VIVUS Reports Narrower-than-Expected Loss on Qsymia Sales
Yahoo/Zacks.com
Friday, August 8, 2014 - 11:40am
tags:
Vivus, earnings
Biosimilar preclinical demand growing as US market beckons, says Harlan
Biopharma-Reporter
Friday, August 8, 2014 - 9:34am
tags:
biosimilars, Sandoz, Novartis, FDA
Fujifilm Drug Eyed As Possible Treatment for Ebola Virus
WSJ Online
Friday, August 8, 2014 - 9:12am
tags:
ebola virus, Fujifilm, favipiravir, Toyama Chemical Co.
Roche Rebuked by U.K. on $152,850 Breast Cancer Drug
Bloomberg
Friday, August 8, 2014 - 8:44am
tags:
UK, Roche, breast cancer, Kadcyla
Nicox to co-promote eye drug with Bausch + Lomb in the US
Yahoo/Reuters
Friday, August 8, 2014 - 8:43am
tags:
NicOx, Bausch & Lomb, Valeant Pharmaceuticals, latanoprostene
Ebola Drug Firm Shares Go Bonkers After FDA Announcement
Yahoo/Business Insider
Friday, August 8, 2014 - 8:42am
tags:
FDA, Tekmira Pharmaceuticals, TKM-EBOLA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.